KalVista Pharmaceuticals, Inc. (KALV) — Institutional Holders, Q2 2026
1 institutional investment managers reported a KALV position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $189.00. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
KALV in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- IFP AdvisorsNew · +7 sh+$189.00
Biggest sellers
- VR AdviserSold out · -6,474,485 sh-$174.8M
- Frazier Life Sciences Management, L.P.Sold out · -4,961,108 sh-$133.9M
- SUVRETTA CAPITAL MANAGEMENTSold out · -4,768,712 sh-$128.8M
- TANG CAPITAL MANAGEMENTSold out · -4,573,530 sh-$123.5M
- BlackRockSold out · -3,795,897 sh-$102.5M
KALV 13F holders ranked 1–1 of 1
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | IFP Advisors#1 · 7 sh | 7 | $189.00 | — | New |
Funds that sold out of KALV in Q2 2026 (181)
Held KALV at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| VR Adviser6,474,485 sh | 6,474,485 | $130.3M |
| Frazier Life Sciences Management, L.P.4,961,108 sh | 4,961,108 | $99.9M |
| SUVRETTA CAPITAL MANAGEMENT4,768,712 sh | 4,768,712 | $96.0M |
| TANG CAPITAL MANAGEMENT4,573,530 sh | 4,573,530 | $92.1M |
| BlackRock3,795,897 sh | 3,795,897 | $76.4M |
| SILVERARC CAPITAL MANAGEMENT2,876,407 sh | 2,876,407 | $57.9M |
| Capital World Investors2,808,583 sh | 2,808,583 | $56.5M |
| Point72 Asset Management, L.P.2,136,940 sh | 2,136,940 | $43.0M |
| STATE STREET1,955,844 sh | 1,955,844 | $39.4M |
| MILLENNIUM MANAGEMENT1,912,146 sh | 1,912,146 | $38.5M |
| Vestal Point Capital1,850,000 sh | 1,850,000 | $37.2M |
| Parkman Healthcare Partners1,835,506 sh | 1,835,506 | $36.9M |
| VANGUARD CAPITAL MANAGEMENT1,830,467 sh | 1,830,467 | $36.8M |
| Kynam Capital Management1,820,954 sh | 1,820,954 | $36.7M |
| Woodline Partners1,509,920 sh | 1,509,920 | $30.4M |
| Octagon Capital Advisors1,450,000 sh | 1,450,000 | $29.2M |
| EMERALD ADVISERS1,264,023 sh | 1,264,023 | $25.4M |
| ARMISTICE CAPITAL1,236,000 sh | 1,236,000 | $24.9M |
| Elmind Capital1,021,300 sh | 1,021,300 | $20.6M |
| GEODE CAPITAL MANAGEMENT996,235 sh | 996,235 | $20.1M |
| Squadron Capital Management985,100 sh | 985,100 | $19.8M |
| Spruce Street Capital897,681 sh | 897,681 | $18.1M |
| Freestone Grove Partners882,906 sh | 882,906 | $17.8M |
| GOLDMAN SACHS GROUP824,293 sh | 824,293 | $16.6M |
| EMERALD MUTUAL FUND ADVISERS805,762 sh | 805,762 | $16.2M |
| GREAT POINT PARTNERS675,000 sh | 675,000 | $13.6M |
| Bank of New York Mellon584,347 sh | 584,347 | $11.8M |
| DRIEHAUS CAPITAL MANAGEMENT564,039 sh | 564,039 | $11.4M |
| BANK OF AMERICA555,628 sh | 555,628 | $11.2M |
| BARCLAYS PLC537,061 sh | 537,061 | $10.8M |
| UBS Group AG515,650 sh | 515,650 | $10.4M |
| SCHRODER INVESTMENT MANAGEMENT GROUP506,743 sh | 506,743 | $9.3M |
| MORGAN STANLEY439,099 sh | 439,099 | $8.8M |
| Catalio Capital Management426,551 sh | 426,551 | $8.6M |
| Hennion & Walsh Asset Management375,995 sh | 375,995 | $7.6M |
| NORTHERN363,694 sh | 363,694 | $7.3M |
| VANGUARD PORTFOLIO MANAGEMENT362,900 sh | 362,900 | $7.3M |
| SEB Asset Management AB351,305 sh | 351,305 | $7.1M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT323,451 sh | 323,451 | $6.5M |
| Schonfeld Strategic Advisors315,537 sh | 315,537 | $6.4M |
| HRT FINANCIAL286,916 sh | 286,916 | $5.8M |
| LEUCADIA NATIONAL286,046 sh | 286,046 | $5.8M |
| Ishara Investments276,750 sh | 276,750 | $5.6M |
| VANGUARD FIDUCIARY276,391 sh | 276,391 | $5.6M |
| DAFNA Capital Management267,402 sh | 267,402 | $5.4M |
| Atom Investors245,993 sh | 245,993 | $5.0M |
| CITIGROUP244,261 sh | 244,261 | $4.9M |
| AMERIPRISE FINANCIAL229,984 sh | 229,984 | $4.6M |
| F/m Investments226,991 sh | 226,991 | $4.6M |
| Blue Owl Capital215,000 sh | 215,000 | $4.3M |
| FMR187,848 sh | 187,848 | $3.8M |
| Qube Research & Technologies Ltd180,314 sh | 180,314 | $3.6M |
| ExodusPoint Capital Management177,274 sh | 177,274 | $3.6M |
| MARSHALL WACE, LLP162,908 sh | 162,908 | $3.3M |
| NAN FUNG TRINITY (HK) Ltd154,522 sh | 154,522 | $3.1M |
| TWO SIGMA INVESTMENTS153,459 sh | 153,459 | $3.1M |
| Squarepoint Ops143,966 sh | 143,966 | $2.9M |
| RAYMOND JAMES FINANCIAL140,651 sh | 140,651 | $2.8M |
| Trexquant Investment139,458 sh | 139,458 | $2.8M |
| NEXTBio Capital Management131,796 sh | 131,796 | $2.7M |
| Seven Fleet Capital Management128,487 sh | 128,487 | $2.6M |
| Brevan Howard Capital Management125,049 sh | 125,049 | $2.4M |
| WELLINGTON MANAGEMENT GROUP LLP107,262 sh | 107,262 | $2.2M |
| Nuveen106,864 sh | 106,864 | $2.2M |
| CITADEL ADVISORS97,726 sh | 97,726 | $2.0M |
| ORBIMED ADVISORS94,400 sh | 94,400 | $1.9M |
| Walleye Capital79,666 sh | 79,666 | $1.6M |
| XTX Topco Ltd79,118 sh | 79,118 | $1.6M |
| Invesco Ltd.75,282 sh | 75,282 | $1.5M |
| MARTINGALE ASSET MANAGEMENT L P69,945 sh | 69,945 | $1.4M |
| Swiss Life Asset Management Ltd21,885 sh | 21,885 | $1.4M |
| Campbell & Investment Adviser64,249 sh | 64,249 | $1.3M |
| Creative Planning59,986 sh | 59,986 | $1.2M |
| Rafferty Asset Management57,296 sh | 57,296 | $1.2M |
| Birchview Capital57,000 sh | 57,000 | $1.1M |
| Russell Investments Group, Ltd.56,192 sh | 56,192 | $1.1M |
| Swiss National Bank54,900 sh | 54,900 | $1.1M |
| CenterBook Partners53,264 sh | 53,264 | $1.1M |
| PANAGORA ASSET MANAGEMENT50,792 sh | 50,792 | $1.0M |
| Virtus Investment Advisers49,927 sh | 49,927 | $1.0M |
| RHUMBLINE ADVISERS47,469 sh | 47,469 | $955.5K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP46,760 sh | 46,760 | $941.3K |
| Lisanti Capital Growth43,775 sh | 43,775 | $881.2K |
| Man Group plc42,576 sh | 42,576 | $857.1K |
| ALPS ADVISORS41,149 sh | 41,149 | $828.3K |
| DEUTSCHE BANK AG\38,857 sh | 38,857 | $782.2K |
| AQR CAPITAL MANAGEMENT37,572 sh | 37,572 | $756.3K |
| Quadrature Capital Ltd35,123 sh | 35,123 | $707.0K |
| Ikarian Capital35,119 sh | 35,119 | $706.9K |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME34,743 sh | 34,743 | $699.4K |
| Y-Intercept (Hong Kong) Ltd33,776 sh | 33,776 | $679.9K |
| Quarry33,750 sh | 33,750 | $679.4K |
| Quantinno Capital Management32,453 sh | 32,453 | $653.3K |
| EVOKE WEALTH31,542 sh | 31,542 | $634.9K |
| PRICE T ROWE ASSOCIATES29,367 sh | 29,367 | $592.0K |
| ALLIANCEBERNSTEIN L.P.33,580 sh | 33,580 | $542.3K |
| AXQ CAPITAL26,850 sh | 26,850 | $540.5K |
| PROFUND ADVISORS25,660 sh | 25,660 | $516.5K |
| Verition Fund Management25,500 sh | 25,500 | $513.3K |
| Zurcher Kantonalbank (Zurich Cantonalbank)24,296 sh | 24,296 | $489.1K |
And 81 smaller positions.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.